Background Molecular analysis (MA) on heart valve (HV) improves the microbiologic diagnosis of infectious endocarditis (IE). The main drawback of MA is the lack of antimicrobial susceptibility information. Methods We conducted a prospective cohort observational study of consecutive adult patients from April 2012 to May 2021 who underwent valve surgery at our hospital. The performance of MA, blood cultures (BC) and valve cultures (VC), and the diagnostic and therapeutic impact of MA were evaluated. Molecular antibiogram results were compared to culture-based antimicrobial susceptibility testing (AST). Results A total of 137 patients with definite IE and 52 patients with no IE were enrolled in the study. Among IE cases BC, VC, and MA were positive in 75 (55%), 30 (22%), and 120 (88%) of IE cases, respectively. Among 62 cases of BC-negative IE (BCNE), 57 achieved diagnosis with MA. MA led to a change of antimicrobial therapy in 92% of BCNE. MA was negative in 100% of patients with no IE. Molecular antibiogram performed on 17 valve specimens that resulted positive for pathogens potential carrier of genes encoding for multidrug resistant mechanisms showed 100% concordance with AST. Conclusions MA showed a high specificity and sensitivity in etiological diagnosis of IE. Molecular antibiogram could overcome the major limitation of MA that is the lack of susceptibility testing. We advocate for the inclusion of MA among diagnostic criteria for IE and for a more extensive use of molecular antibiogram when the culture result is negative, and MA is the only positive test.Molecular analysis improved the diagnosis of endocarditis and led to a change of antimicrobial therapy in 92% of cases of blood-culture-negative endocarditis. Molecular antibiogram on heart valve should be used in culture-negative and molecular analysis-positive cases to provide susceptibility data.

Mularoni, A., Mikulska, M., Barbera, F., Graziano, E., Medaglia, A.A., Di Carlo, D., et al. (2022). Molecular Analysis with16s rRNA PCR/Sanger Sequencing and Molecular Antibiogram performed on DNA extracted from valve improve diagnosis and targeted therapy of Infective Endocarditis: a prospective study. CLINICAL INFECTIOUS DISEASES [10.1093/cid/ciac452].

Molecular Analysis with16s rRNA PCR/Sanger Sequencing and Molecular Antibiogram performed on DNA extracted from valve improve diagnosis and targeted therapy of Infective Endocarditis: a prospective study

Cascio, Antonio;
2022-06-10

Abstract

Background Molecular analysis (MA) on heart valve (HV) improves the microbiologic diagnosis of infectious endocarditis (IE). The main drawback of MA is the lack of antimicrobial susceptibility information. Methods We conducted a prospective cohort observational study of consecutive adult patients from April 2012 to May 2021 who underwent valve surgery at our hospital. The performance of MA, blood cultures (BC) and valve cultures (VC), and the diagnostic and therapeutic impact of MA were evaluated. Molecular antibiogram results were compared to culture-based antimicrobial susceptibility testing (AST). Results A total of 137 patients with definite IE and 52 patients with no IE were enrolled in the study. Among IE cases BC, VC, and MA were positive in 75 (55%), 30 (22%), and 120 (88%) of IE cases, respectively. Among 62 cases of BC-negative IE (BCNE), 57 achieved diagnosis with MA. MA led to a change of antimicrobial therapy in 92% of BCNE. MA was negative in 100% of patients with no IE. Molecular antibiogram performed on 17 valve specimens that resulted positive for pathogens potential carrier of genes encoding for multidrug resistant mechanisms showed 100% concordance with AST. Conclusions MA showed a high specificity and sensitivity in etiological diagnosis of IE. Molecular antibiogram could overcome the major limitation of MA that is the lack of susceptibility testing. We advocate for the inclusion of MA among diagnostic criteria for IE and for a more extensive use of molecular antibiogram when the culture result is negative, and MA is the only positive test.Molecular analysis improved the diagnosis of endocarditis and led to a change of antimicrobial therapy in 92% of cases of blood-culture-negative endocarditis. Molecular antibiogram on heart valve should be used in culture-negative and molecular analysis-positive cases to provide susceptibility data.
Mularoni, A., Mikulska, M., Barbera, F., Graziano, E., Medaglia, A.A., Di Carlo, D., et al. (2022). Molecular Analysis with16s rRNA PCR/Sanger Sequencing and Molecular Antibiogram performed on DNA extracted from valve improve diagnosis and targeted therapy of Infective Endocarditis: a prospective study. CLINICAL INFECTIOUS DISEASES [10.1093/cid/ciac452].
File in questo prodotto:
File Dimensione Formato  
Molecular Analysis with16s rRNA PCR Sanger Sequencing and Molecular Antibiogram performed on DNA extracted from valve improve diagnosis and targeted therapy of Infective Endocarditis.pdf

Solo gestori archvio

Tipologia: Versione Editoriale
Dimensione 460.51 kB
Formato Adobe PDF
460.51 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/574590
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 1
social impact